In 2010, Stryker received subpoenas from the U.S. Department of Justice regarding the OtisKnee. The subpoena filed with the Securities and Exchange Commission regarded regulatory matters related to the sales and marketing of the devices.
The OtisKnee device was manufactured by OtisMed, which Stryker acquired in 2009. The federal government has yet to accept the offer.
Related Articles on Stryker:
InVivo Therapeutics Names Former Stryker Exec Robert Housler Vice President of Business Development
Former Stryker CEO Stephen MacMillan Seeking Johnson & Johnson Position
Stryker, Others Found Environmentally Preferable Purchasing Business Leadership Coalition
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.